NYSE:CAH - Cardinal Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$52.39 -1.34 (-2.49 %)
(As of 12/14/2018 04:57 AM ET)
Previous Close$53.73
Today's Range$51.92 - $53.78
52-Week Range$48.14 - $75.75
Volume2.95 million shs
Average Volume3.40 million shs
Market Capitalization$15.95 billion
P/E Ratio10.48
Dividend Yield3.56%
Beta0.92
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company operates through two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. It also provides services to support the development, marketing, and distribution of specialty pharmaceutical products, as well as pharmacy management, and medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products. It also distributes a range of national brand products; and medical products to patients' homes, as well as provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

Receive CAH News and Ratings via Email

Sign-up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Current SymbolNYSE:CAH
Previous Symbol
CUSIP14149Y10
Phone614-757-5000

Debt

Debt-to-Equity Ratio1.35
Current Ratio1.06
Quick Ratio0.52

Price-To-Earnings

Trailing P/E Ratio10.48
Forward P/E Ratio10.48
P/E Growth1.71

Sales & Book Value

Annual Sales$136.81 billion
Price / Sales0.11
Cash Flow$8.2245 per share
Price / Cash Flow6.37
Book Value$19.50 per share
Price / Book2.69

Profitability

EPS (Most Recent Fiscal Year)$5.00
Net Income$256 million
Net Margins0.53%
Return on Equity23.97%
Return on Assets3.97%

Miscellaneous

Employees32,300
Outstanding Shares297,940,000
Market Cap$15.95 billion
OptionableOptionable

Cardinal Health (NYSE:CAH) Frequently Asked Questions

What is Cardinal Health's stock symbol?

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health announced a quarterly dividend on Thursday, November 8th. Investors of record on Wednesday, January 2nd will be paid a dividend of $0.4763 per share on Tuesday, January 15th. This represents a $1.91 dividend on an annualized basis and a yield of 3.64%. The ex-dividend date is Monday, December 31st. View Cardinal Health's Dividend History.

How will Cardinal Health's stock buyback program work?

Cardinal Health announced that its board has authorized a stock repurchase plan on Thursday, November 8th 2018, which allows the company to repurchase $1,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 6.4% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's management believes its stock is undervalued.

How were Cardinal Health's earnings last quarter?

Cardinal Health Inc (NYSE:CAH) announced its earnings results on Thursday, November, 8th. The company reported $1.29 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.08 by $0.21. The firm had revenue of $35.21 billion for the quarter, compared to analyst estimates of $33.66 billion. Cardinal Health had a net margin of 0.53% and a return on equity of 23.97%. The firm's revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the previous year, the company earned $1.09 earnings per share. View Cardinal Health's Earnings History.

When is Cardinal Health's next earnings date?

Cardinal Health is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for Cardinal Health.

What guidance has Cardinal Health issued on next quarter's earnings?

Cardinal Health issued an update on its FY19 earnings guidance on Thursday, November, 8th. The company provided earnings per share guidance of $4.90-5.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.00. Cardinal Health also updated its FY 2019 guidance to $4.90-5.15 EPS.

What price target have analysts set for CAH?

10 brokerages have issued twelve-month price objectives for Cardinal Health's stock. Their predictions range from $50.00 to $75.00. On average, they anticipate Cardinal Health's stock price to reach $60.50 in the next twelve months. This suggests a possible upside of 15.5% from the stock's current price. View Analyst Price Targets for Cardinal Health.

What is the consensus analysts' recommendation for Cardinal Health?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 2 sell ratings, 7 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cardinal Health.

Has Cardinal Health been receiving favorable news coverage?

Media stories about CAH stock have been trending somewhat positive on Friday, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cardinal Health earned a news impact score of 1.7 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the company's share price in the immediate future.

Who are some of Cardinal Health's key competitors?

Who are Cardinal Health's key executives?

Cardinal Health's management team includes the folowing people:
  • Mr. Michael C. Kaufmann, CEO & Director (Age 55)
  • Mr. Jorge M. Gomez, Chief Financial Officer (Age 50)
  • Mr. Craig S. Morford, Chief Legal & Compliance Officer (Age 59)
  • Mr. Jon L. Giacomin, Chief Exec. Officer of Medical Segment (Age 53)
  • Mr. Stuart G. Laws, Sr. VP & Chief Accounting Officer (Age 55)

Who are Cardinal Health's major shareholders?

Cardinal Health's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Vanguard Group Inc (9.41%), BlackRock Inc. (8.00%), Macquarie Group Ltd. (4.65%), FMR LLC (2.66%), Bank of New York Mellon Corp (2.61%) and American International Group Inc. (2.46%). Company insiders that own Cardinal Health stock include George S Barrett, Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

Which institutional investors are selling Cardinal Health stock?

CAH stock was sold by a variety of institutional investors in the last quarter, including Bridgewater Associates LP, JPMorgan Chase & Co., JPMorgan Chase & Co., FMR LLC, Mitsubishi UFJ Trust & Banking Corp, Morgan Stanley, Baupost Group LLC MA and Baupost Group LLC MA. Company insiders that have sold Cardinal Health company stock in the last year include Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Insider Buying and Selling for Cardinal Health.

Which institutional investors are buying Cardinal Health stock?

CAH stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc, Renaissance Technologies LLC, Bank of New York Mellon Corp, Macquarie Group Ltd., Deutsche Bank AG, Panagora Asset Management Inc., American Century Companies Inc. and Schroder Investment Management Group. View Insider Buying and Selling for Cardinal Health.

How do I buy shares of Cardinal Health?

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cardinal Health's stock price today?

One share of CAH stock can currently be purchased for approximately $52.39.

How big of a company is Cardinal Health?

Cardinal Health has a market capitalization of $15.95 billion and generates $136.81 billion in revenue each year. The company earns $256 million in net income (profit) each year or $5.00 on an earnings per share basis. Cardinal Health employs 32,300 workers across the globe.

What is Cardinal Health's official website?

The official website for Cardinal Health is http://www.cardinalhealth.com.

How can I contact Cardinal Health?

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]


MarketBeat Community Rating for Cardinal Health (NYSE CAH)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  636 (Vote Outperform)
Underperform Votes:  451 (Vote Underperform)
Total Votes:  1,087
MarketBeat's community ratings are surveys of what our community members think about Cardinal Health and other stocks. Vote "Outperform" if you believe CAH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CAH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/14/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel